Q4 2017 13F Holders as of 31 Dec 2017
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
114,331,829
-
Total 13F shares
-
35,345,824
-
Share change
-
+9,944,719
-
Total reported value
-
$214,129,408
-
Price per share
-
$6.11
-
Number of holders
-
77
-
Value change
-
+$65,332,083
-
Number of buys
-
46
-
Number of sells
-
30
Institutional Holders of FATE THERAPEUTICS INC - Common Stock, par value $0.001 per share (FATE) as of Q4 2017
As of 31 Dec 2017,
FATE THERAPEUTICS INC - Common Stock, par value $0.001 per share (FATE) was held by
77 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
35,345,824 shares.
The largest 10 holders included
FMR LLC, FRANKLIN RESOURCES INC, Redmile Group, LLC, Casdin Capital, LLC, Polaris Venture Management Co. V, L.L.C., BlackRock Inc., Vanguard Group Inc, 683 Capital Management, LLC, Endurant Capital Management LP, and STATE STREET CORP.
This page lists
77
institutional shareholders reporting positions in this security
for the Q4 2017 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.